Business · 10/07/1997

FDA Approves Kensey Nash Corp.'s Angio-Seal Hemostatic Puncture Closure Device

The US Food and Drug Administration (FDA) has granted premarket approval for Kensey Nash Corp.'s Angio-SealTM Hemostatic Puncture Closure Device, following a recommendation from the Circulatory System Devices Panel, as announced on September 30, 1996.